ZCCHC7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.66133814775094E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62458935193399E-12 |
Normal-vs-Stage2 |
1.13319999994754E-06 |
Normal-vs-Stage3 |
2.00260000005059E-06 |
Normal-vs-Stage4 |
2.20139999995705E-06 |
Stage1-vs-Stage2 |
7.579600E-01 |
Stage1-vs-Stage3 |
5.018100E-03 |
Stage1-vs-Stage4 |
6.768600E-01 |
Stage2-vs-Stage3 |
4.778200E-02 |
Stage2-vs-Stage4 |
6.014000E-01 |
Stage3-vs-Stage4 |
1.424800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
3.884800E-03 |
Normal-vs-Asian |
7.571500E-02 |
Caucasian-vs-AfricanAmerican |
3.399100E-03 |
Caucasian-vs-Asian |
8.363200E-01 |
AfricanAmerican-vs-Asian |
3.642600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.21964677141295E-15 |
Normal-vs-Female |
1.05360165036927E-11 |
Male-vs-Female |
2.892000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.720200E-03 |
Normal-vs-Age(41-60Yrs) |
1.79856129989275E-14 |
Normal-vs-Age(61-80Yrs) |
4.20707912951457E-12 |
Normal-vs-Age(81-100Yrs) |
1.356070E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.365200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.442000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.332000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.495600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.370200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.361000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.236910E-03 |
Normal-vs-Grade 2 |
1.62436730732907E-12 |
Normal-vs-Grade 3 |
3.77819997510187E-10 |
Normal-vs-Grade 4 |
1.617210E-03 |
Grade 1-vs-Grade 2 |
9.665200E-01 |
Grade 1-vs-Grade 3 |
1.733050E-01 |
Grade 1-vs-Grade 4 |
2.913800E-01 |
Grade 2-vs-Grade 3 |
7.381400E-04 |
Grade 2-vs-Grade 4 |
2.652300E-02 |
Grade 3-vs-Grade 4 |
7.392800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
2.5823999999508E-06 |
ccA subtype-vs-ccB subtype |
1.69189999787989E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.42075240461281E-12 |
Normal-vs-N1 |
6.618300E-02 |
N0-vs-N1 |
8.263000E-01 |
|
|